Skip to main content
Menu

AlphaLISA SureFire Biotin-Free Human and Mouse Total ATF-3 Detection Kit, 100 Assay Points

The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total ATF-3 assay is a sandwich immunoassay for quantitative detection of total ATF-3 in cellular lysates using Alpha Technology.

Feature Specification
Application Cell Signaling
Protocol Time 2h at RT
Sample Volume 30 µL

The AlphaLISA™ SureFire® Biotin-Free Human and Mouse Total ATF-3 assay is a sandwich immunoassay for quantitative detection of total ATF-3 in cellular lysates using Alpha Technology.

Product variants
Compare all
Remove all
Add to compare Add to compare
Remove
Unit Size: 100 Assay Points
Part #:
ASBF-TATF3-A-HV
List price
USD 737.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 500 Assay Points
Part #:
ASBF-TATF3-A500
List price
USD 2,490.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 10,000 Assay Points
Part #:
ASBF-TATF3-A10K
List price
USD 14,982.00
Your price:
Add to compare Add to compare
Remove
Unit Size: 50,000 Assay Points
Part #:
ASBF-TATF3-A50K
List price
USD 47,624.00
Your price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Loading...

Overview

Activating Transcription Factor 3 (ATF-3) is a stress-inducible member of the ATF/CREB family of basic leucine zipper (bZIP) transcription factors that is rapidly upregulated in response to diverse cellular stresses including DNA damage, oxidative stress, cytokines, and growth factor withdrawal. ATF-3 can function as either a transcriptional repressor or activator depending on its dimerization partner; as a homodimer it typically represses transcription, while heterodimers with other bZIP proteins such as ATF2, c-Jun, or c-Fos can activate target gene expression. ATF-3 regulates genes involved in apoptosis, inflammation, cell cycle arrest, and metabolic adaptation, positioning it as a key integrator of stress response programs. In cancer, ATF-3 exhibits context-dependent roles: it functions as a tumor suppressor in colorectal and prostate cancers by promoting apoptosis and inhibiting invasion, but can also support tumor progression in breast cancer by modulating the tumor microenvironment and promoting metastasis. ATF-3 has also been implicated in immune regulation, where it modulates Toll-like receptor signaling and inflammatory cytokine production in macrophages, linking it to innate immunity and inflammatory disease.

The AlphaLISA SureFire Biotin-Free Human and Mouse Total ATF-3 Detection Kit is a sandwich immunoassay for the quantitative detection of total ATF-3 in cellular lysates, using Alpha Technology.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Biotin Free kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies
  • Biotin rich samples

AlphaLISA SureFire Biotin Free kits can be used for:

  • Cellular kinase assays
  • Receptor activation studies
  • High-throughput screening for preclinical studies

How it works

Total-AlphaLISA SureFire Biotin Free assay principle

The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).

The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.

Total-AlphaLISA SureFire Ultra Biotin Free assay principle

 

Total-AlphaLISA SureFire Biotin Free two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2 plates assay protocol alphalisa surefire ultra biotin free total assay

Total-AlphaLISA SureFire Biotin Free one-plate assay protocol

Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.

1 plate assay protocol alphalisa surefire ultra biotin free total assay

Assay validation

LPS induction of ATF-3 expression

RPMI 8226 cells were seeded in a 96-well plate (200,000 cells/well) in complete medium and treated with 1 µg/mL LPS for the indicated times at 37°C, 5% CO2.

After treatment, the cells were spun down and lysed with 65 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (approximately 30,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, LPS treatment induced ATF-3 expression after 2 hours, reaching maximal levels after 6 hours.

Pharmacological Validation (Induction) of ATF-3 Total assay

R848 induction of ATF-3 expression

RPMI 8226 cells were seeded in a 96-well plate (200,000 cells/well) in complete medium and treated with 5 µM R848 at indicated times at 37°C, 5% CO2.

After treatment, the cells were spun down and lysed with 50 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (approximately 40,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

R848 is a TLR7/8 agonist that mimics pathogen-associated molecular patterns triggering innate immune responses. R848 induced ATF-3 expression after 2 hours, reaching maximal levels after 6 hours.

Pharmacological Validation (Induction) of ATF-3 Total assay

Induction of ATF-3 by LPS in a dose dependent manner

RPMI 8226 cells were seeded in a 96-well plate (200,000 cells/well) in complete medium and treated with increasing concentrations of LPS for 4 hours at 37°C, 5% CO2.

After treatment, the cells were spun down and lysed with 65 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). ATF-3 Total and IRF5 Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 30,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, LPS treatment resulted in a dose dependent increase in the levels of ATF-3 with no significant changes in IFR5 Total signal.

Pharmacological Validation (Induction) of ATF-3 Total assay

RAW 264.7 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. Cells were treated with increasing concentrations of LPS for 4 hours.

After treatment, the cells were lysed with 30 µL or 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). ATF-3 and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 20,000 cells for ATF-3 Total and 6,000 cells for ERK Total) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, LPS resulted in a dose dependent increase in the levels of ATF-3 while ERK Total levels remained unchanged.

Pharmacological Validation (Induction) of ATF-3 Total assay

Assay specificity/selectivity

Assay specificity - knockout validation

ATF-3 levels were assessed in HCT-116 (WT) and ATF-3 KO (Abcam, ab266872) cell lines cultured to confluency in T175 flasks at 37°C, 5% CO2. Cells were lysed in 4 mL of Lysis Buffer for 10 minutes at RT with shaking.

Lysate was serially diluted in Lysis Buffer and ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Approximate number of cells per datapoint is indicated. The dotted line represents assay background. ATF-3 was detected in WT but not KO cells, confirming the specificity of the assay for the detection of ATF-3 protein.

ATF-3 Total assay specificity

Assay versatility

ATF-3 expression in various cell lines

Adherent cells were grown to confluency in a T175 flask in complete medium and lysed with Lysis Buffer at a density of 2 x 106 cells/mL. Suspension cells were harvested, spun down and lysed with Lysis Buffer at a density of 1.6 x 106 cells/mL.

ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of cell lysate (20,000 adherent and 16,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

ATF-3 is a stress inducible gene and basal expression was detected in a range of human cell lines and in RAW 264.7 mouse cells. As expected HCT-116 cells have elevated endogenous levels of ATF-3.

ATF-3 Total assay versatility

Assay sensitivity

Assay sensitivity - cell lysate dilution

Cell lysate was prepared from HCT-116 cells cultured to confluence in a T175 flask and lysed in 3 mL of Lysis Buffer for 10 minutes at RT with shaking.

Lysate was serially diluted in Lysis Buffer and ATF-3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Approximate number of cells per datapoint is indicated. The dotted line represents assay background. This assay can detect endogenous ATF-3 expression in less than 2,500 HCT-116 cells.

ATF-3 Total assay sensitivity

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
AlphaLISA SureFire Biotin-Free
Detection Modality
Alpha
Product Group
Kit
Protocol Time
2h at RT
Sample Volume
30 µL
Shipping Conditions
Shipped in Blue Ice
Target
ATF-3
Target Class
Phosphoproteins
Target Species
Human
Mouse
Technology
Alpha
Therapeutic Area
Inflammation
Oncology
Unit Size
100 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

1-3 of 3 Resources
Brochure Icon
Brochure
Alpha assays and reagents catalog

Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...

Brochure Icon
Brochure
Alpha SureFire Ultra no-wash immunoassay catalog

Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...

Brochure Icon
Brochure
Species compatibility for HTRF, AlphaLISA SureFire Ultra and Alpha SureFire Ultra Multiplex assays

This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...

Loading...

Revvity AI Assistant Beta

Scroll Icon